We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+2.67%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$46.3B
AUM Growth
+$3.2B
Cap. Flow
+$2.34B
Cap. Flow %
5.06%
Top 10 Hldgs %
17.9%
Holding
3,541
New
248
Increased
1,836
Reduced
1,143
Closed
207

Sector Composition

Rank Sector Weight
1 Technology 9.28%
2 Healthcare 9.23%
3 Financials 8.81%
4 Industrials 6.85%
5 Communication Services 6.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SFNC icon
2551
Simmons First National
SFNC
$3.4B
$392K ﹤0.01%
14,818
+4
+0% +$106
ASH icon
2552
Ashland
ASH
$3.35B
$390K ﹤0.01%
5,911
-7,263
-55% -$462K
AGX icon
2553
Argan
AGX
$8.34B
$389K ﹤0.01%
6,480
+466
+8% +$30.1K
MUE
2554
DELISTED
BlackRock MuniHoldings Quality Fund II
MUE
$389K ﹤0.01%
28,552
+4,868
+21% +$66.2K
MDR
2555
DELISTED
McDermott International
MDR
$386K ﹤0.01%
17,962
-1,158
-6% -$22.7K
GIMO
2556
DELISTED
Gigamon Inc.
GIMO
$386K ﹤0.01%
9,810
-3,323
-25% -$125K
WHF icon
2557
WhiteHorse Finance
WHF
$145M
$385K ﹤0.01%
28,777
+5,000
+21% +$71K
TRUE
2558
DELISTED
TrueCar
TRUE
$384K ﹤0.01%
19,250
-4,300
-18% -$74.1K
IDA icon
2559
Idacorp
IDA
$8.22B
$383K ﹤0.01%
+4,490
New +$385K
USNA icon
2560
Usana Health Sciences
USNA
$283M
$383K ﹤0.01%
5,971
+1,086
+22% +$66.9K
BICK
2561
DELISTED
First Trust BICK Index Fund
BICK
$383K ﹤0.01%
+14,719
New +$374K
KATE
2562
DELISTED
Kate Spade & Company
KATE
$383K ﹤0.01%
+20,722
New +$382K
GAP
2563
The Gap Inc
GAP
$7.36B
$381K ﹤0.01%
17,339
-35,763
-67% -$851K
WIP icon
2564
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$474M
$380K ﹤0.01%
6,836
GNRC icon
2565
Generac Holdings
GNRC
$12.6B
$379K ﹤0.01%
10,497
-2,177
-17% -$77.8K
CRL icon
2566
Charles River Laboratories
CRL
$12.5B
$378K ﹤0.01%
3,734
-1,783
-32% -$164K
CVEO icon
2567
Civeo
CVEO
$313M
$378K ﹤0.01%
14,983
-8,487
-36% -$253K
DK icon
2568
Delek US
DK
$3.59B
$378K ﹤0.01%
+14,292
New +$353K
ELF icon
2569
e.l.f. Beauty
ELF
$5.82B
$378K ﹤0.01%
13,893
+680
+5% +$18.1K
EDIV icon
2570
State Street SPDR S&P Emerging Markets Dividend ETF
EDIV
$1.23B
$377K ﹤0.01%
+12,634
New +$375K
WLKP icon
2571
Westlake Chemical Partners
WLKP
$762M
$377K ﹤0.01%
15,230
+522
+4% +$12.9K
PEGI
2572
DELISTED
Pattern Energy Group Inc. Class A
PEGI
$376K ﹤0.01%
15,776
-481
-3% -$10.8K
UCO icon
2573
ProShares Ultra Bloomberg Crude Oil
UCO
$395M
$375K ﹤0.01%
4,040
-40
-1% -$4.19K
MU icon
2574
CALL
Micron Technology
MU
$983B
$374K ﹤0.01%
46,000
-22,500
-33% -$658K
PSR icon
2575
Invesco Active US Real Estate Fund
PSR
$60.1M
$374K ﹤0.01%
+4,743
New +$370K

Similar funds

Raymond James & Associates's Q2 2017 Portfolio in Review

As of Q2 2017, Raymond James & Associates held 3,541 positions worth $46.3B, up 7.4% from $43.1B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Raymond James & Associates deployed $2.34B of net new capital in Q2 2017, opening 248 new positions and adding to 1,836 existing holdings. Its largest new stake was DXC Technology: 324,843 shares worth $21.6M.

By sector, the portfolio is most concentrated in Technology at 9.3% of assets, down from 9.6% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Novartis, an estimated $53.7M trimmed.

  • Raymond James & Associates's largest Q2 2017 buy was DXC Technology: 324,843 shares worth $21.6M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2017, an estimated $308M increase.
  • Raymond James & Associates's biggest Q2 2017 reduction was Novartis, cutting an estimated $53.7M.
  • Raymond James & Associates fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $24.9M.
  • Raymond James & Associates's ten largest holdings make up 18% of its $46.3B portfolio in Q2 2017.
  • Raymond James & Associates opened 248 new positions and closed 207 in Q2 2017.
  • Raymond James & Associates's portfolio value rose 7.4% quarter-over-quarter to $46.3B.

Based on Raymond James & Associates's 13F filing for Q2 2017, filed 14 Aug 2017.